Please pay attention to these brief quotes from a 2007 paper on pyroglutamic acid (aka 5-OP). 5-OP is an ingredient of AOR Ortho-Mind and, from what I've read from Michael, is the mother-molecule from which all the various racetams are derived. Michael seems to endorse the safety of 5-OP, on grounds that it is an orthomolecule. On his webpage I've seen that he's taking more 5-OP than piracetam, for example.
However, the quotes below clearly indicate that the toxicity of 5-OP was known from 1973 onwards, with studies cited from 1973, 1984, 1985, 1989, 1990, 1993, 2001. I don't understand Michael's claims and AOR's claims about the safety of 5-OP, given all these references about 5-OP neurotoxicity.
I hope that my lack of background in biochemistry & pharmacology led me to misinterpret the quotes below, and I beg the members qualified in pharmacology to clarify them for me. Also, what are the implications for the racetams users (I personally take only 5-OP because it's easier to get and because I've bought Michael's arguments).
"5-OP was already shown to be neurotoxic (Rieke et al., 1984; Rieke et al., 1989). This organic acid was shown to promote excitotoxicity (Bennet Jr et al., 1973; Dusticier et al., 1985; Barone and Spignoli, 1990) and inhibit brain energy metabolism (Escobedo and Cravioto, 1973; Silva et al., 2001). In addition, chronic intrastriatal infusion of 5-OP produced selective neuron sparing lesions in the rat striatum (Rieke et al., 1984), which has been assumed to be due to glutamate-induced excitotoxic damage (Rothstein et al., 1993)."
"5-OP was shown to be excitotoxic (Bennet Jr et al., 1973; Rieke et al., 1989; Barone and Spignoli,
1990) as well as to compromise brain energy metabolism by inhibiting Na+,K+-ATPase (Escobedo and Cravioto, 1973; Rieke et al., 1984), reducing CO2 production, ATP and lipid syntheses, and also respiratory chain enzyme activities (Silva et al., 2001)."
"Taken together, our present results clearly indicate that 5-OP decreases the non-enzymatic
antioxidant defenses in rat brain, as shown by the significant reduction observed in TRAP
and TAR measurements, and provokes oxidative damage to proteins, probable by enhancing
RS production in cerebral cortex and cerebellum."
And here is the full abstract & bibliographic details of the paper:
Metab Brain Dis (2007) 22:51–65
DOI 10.1007/s11011-006-9041-2
ORIGINAL PAPER
5-Oxoproline Reduces Non-Enzymatic Antioxidant Defenses in vitro in Rat Brain
Carolina D. Pederzolli · ˆ Angela M. Sgaravatti · C´esar A. Braum · Cristina C. Prestes · Giovanni K. Zorzi · Mirian B. Sgarbi · Angela T. S. Wyse · Cl´ovis M. D. Wannmacher · MoacirWajner · Carlos S. Dutra-Filho
5-Oxoproline (pyroglutamic acid) accumulates in glutathione synthetase deficiency, an inborn metabolic defect of the γ -glutamyl cycle. This disorder is clinically characterized by hemolytic anemia, metabolic acidosis and severe neurological disorders. Considering that the mechanisms of brain damage in this disease are poorly known, in the present study we investigated whether oxidative stress is elicited by 5-oxoproline. The in vitro effect of (0.5–3.0 mM) 5-oxoproline was studied on various parameters of oxidative stress, such as total radical-trapping antioxidant potential, total antioxidant reactivity, chemiluminescence, thiobarbituric acid-reactive substances, sulfhydryl content, carbonyl content, and 2,7-dichlorofluorescein fluorescence, as well as on the activities of the antioxidant enzymes catalase, superoxide dismutase and glutathione peroxidase in cerebral cortex and cerebellum
of 14-day-old rats. Total radical-trapping antioxidant potential and total antioxidant reactivity were significantly reduced in both cerebral structures. Carbonyl content and 2,7-dichlorofluorescein fluorescence were significantly enhanced, while sulfhydryl content was significantly diminished. In contrast, chemiluminescence and thiobarbituric acid-reactive substances were not affected by 5-oxoproline. The activities of catalase, superoxide dismutase and glutathione peroxidase were also not altered by 5-oxoproline. These results indicate that 5-oxoproline causes protein oxidation and reactive species production and decrease the non-enzymatic antioxidant defenses in rat brain, but does not cause lipid peroxidation. Taken together, it may be presumed that 5-oxoproline elicits oxidative stress that may represent a pathophysiological mechanism in the disorder in which this metabolite accumulates.
Edited by chrono, 12 November 2011 - 03:30 AM.